Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000936392-07-000254
Filing Date
2007-04-02
Accepted
2007-04-02 17:25:18
Documents
9
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a28595e10vk.htm 10-K 1193479
2 EXHIBIT 10.1 a28595exv10w1.htm EX-10.1 26883
3 EXHIBIT 14.1 a28595exv14w1.htm EX-14.1 10869
4 EXHIBIT 23.1 a28595exv23w1.htm EX-23.1 2728
5 EXHIBIT 23.2 a28595exv23w2.htm EX-23.2 2304
6 EXHIBIT 31.1 a28595exv31w1.htm EX-31.1 5156
7 EXHIBIT 31.2 a28595exv31w2.htm EX-31.2 5510
8 EXHIBIT 32.1 a28595exv32w1.htm EX-32.1 3877
9 GRAPHIC a28595a2859501.gif GRAPHIC 7776
  Complete submission text file 0000936392-07-000254.txt   1263231
Mailing Address 9 PARKER, SUITE 100 IRVINE CA 92618-1605
Business Address 9 PARKER, SUITE 100 IRVINE CA 92618-1605 949-470-4751
IDM PHARMA, INC. (Filer) CIK: 0000822206 (see all company filings)

EIN.: 330245076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19591 | Film No.: 07740626
SIC: 2834 Pharmaceutical Preparations